Nanoreporter of an Enzymatic Suicide Inactivation Pathway.

Drug development Drug screening Enzymology High throughput assay Reactive oxygen species

Journal

Nano letters
ISSN: 1530-6992
Titre abrégé: Nano Lett
Pays: United States
ID NLM: 101088070

Informations de publication

Date de publication:
11 11 2020
Historique:
pubmed: 30 10 2020
medline: 25 6 2021
entrez: 29 10 2020
Statut: ppublish

Résumé

Enzymatic suicide inactivation, a route of permanent enzyme inhibition, is the mechanism of action for a wide array of pharmaceuticals. Here, we developed the first nanosensor that selectively reports the suicide inactivation pathway of an enzyme. The sensor is based on modulation of the near-infrared fluorescence of an enzyme-bound carbon nanotube. The nanosensor responded selectively to substrate-mediated suicide inactivation of the tyrosinase enzyme via bathochromic shifting of the nanotube emission wavelength. Mechanistic investigations revealed that singlet oxygen generated by the suicide inactivation pathway induced the response. We used the nanosensor to quantify the degree of enzymatic inactivation by measuring response rates to small molecule tyrosinase modulators. This work resulted in a new capability of interrogating a specific route of enzymatic death. Potential applications include drug screening and hit-validation for compounds that elicit or inhibit enzymatic inactivation and single-molecule measurements to assess population heterogeneity in enzyme activity.

Identifiants

pubmed: 33119310
doi: 10.1021/acs.nanolett.0c01858
pmc: PMC8177003
mid: NIHMS1706043
doi:

Substances chimiques

Nanotubes, Carbon 0
Monophenol Monooxygenase EC 1.14.18.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

7819-7827

Subventions

Organisme : NICHD NIH HHS
ID : DP2 HD075698
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS110790
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS116353
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA215719
Pays : United States
Organisme : NCCIH NIH HHS
ID : DP1 AT010874
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK114321
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007739
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM131858
Pays : United States

Références

Nat Nanotechnol. 2009 Feb;4(2):114-20
pubmed: 19197314
Biochim Biophys Acta. 2010 Jul;1804(7):1467-75
pubmed: 20215052
Front Immunol. 2017 Apr 19;8:399
pubmed: 28469620
Int J Dermatol. 2010 Feb;49(2):218-26
pubmed: 20465650
Front Aging Neurosci. 2016 Dec 15;8:303
pubmed: 28018215
Arch Toxicol. 2014 Nov;88(11):1965-85
pubmed: 25212907
IUBMB Life. 2010 Jul;62(7):539-47
pubmed: 20552645
Acc Chem Res. 2003 May;36(5):300-8
pubmed: 12755639
Semin Cancer Biol. 2004 Feb;14(1):13-21
pubmed: 14757532
J Biol Inorg Chem. 2006 Oct;11(7):937-47
pubmed: 16874470
ACS Nano. 2016 Jan 26;10(1):499-506
pubmed: 26654246
Int J Mol Sci. 2009 May 26;10(6):2440-75
pubmed: 19582213
PLoS One. 2013 May 17;8(5):e63506
pubmed: 23691056
Nat Rev Drug Discov. 2005 Oct;4(10):825-33
pubmed: 16224454
Drug Metab Dispos. 2007 Feb;35(2):246-55
pubmed: 17093004
Phys Rev Lett. 2011 Mar 4;106(9):097401
pubmed: 21405650
Int J Mol Sci. 2010 Mar 12;11(3):1082-9
pubmed: 20480001
Metabolism. 2006 Jul;55(7):928-34
pubmed: 16784966
J Phys Chem C Nanomater Interfaces. 2015 May 7;119(18):10048-10058
pubmed: 26005509
Anal Chem. 2015 Jun 16;87(12):6180-5
pubmed: 25986852
Biochim Biophys Acta. 1987 Apr 30;912(3):408-16
pubmed: 3567209
Nat Biomed Eng. 2017;1:
pubmed: 28845337
Proc Natl Acad Sci U S A. 1983 Mar;80(6):1521-5
pubmed: 6572914
J Am Chem Soc. 2011 Jan 26;133(3):567-81
pubmed: 21142158
ACS Nano. 2010 Mar 23;4(3):1511-20
pubmed: 20146506
ACS Sens. 2018 Sep 28;3(9):1838-1845
pubmed: 30169018
Biochim Biophys Acta. 2009 Feb;1794(2):244-53
pubmed: 19010454
Tohoku J Exp Med. 2007 Aug;212(4):341-8
pubmed: 17660699
ACS Nano. 2019 Jul 23;13(7):8222-8228
pubmed: 31244048
Curr Top Med Chem. 2011;11(4):382-403
pubmed: 21320066
Methods. 2012 Aug;57(4):459-66
pubmed: 22750303
Biochem Mol Biol Int. 1995 Oct;37(2):283-93
pubmed: 8673011
Biol Chem. 2009 Mar;390(3):191-214
pubmed: 19166318
Nat Chem. 2016 Feb;8(2):103-13
pubmed: 26791892
J Phys Chem C Nanomater Interfaces. 2010 Oct 28;114(46):19569-19575
pubmed: 21258607
Front Plant Sci. 2017 Apr 26;8:613
pubmed: 28491070
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8544-9
pubmed: 21555544
Biochem Biophys Res Commun. 2016 Mar 18;471(4):450-3
pubmed: 26898801
Biochem Mol Biol Int. 1997 Sep;42(6):1249-60
pubmed: 9305543
Sci Rep. 2015 Sep 21;5:14167
pubmed: 26387482
PLoS One. 2015 Aug 31;10(8):e0136822
pubmed: 26322888
Nat Rev Drug Discov. 2002 Sep;1(9):727-30
pubmed: 12209152
Chem Soc Rev. 2017 Nov 13;46(22):6872-6904
pubmed: 28933459
Biomed Rep. 2018 Jan;8(1):3-10
pubmed: 29399334
Nano Lett. 2014 Sep 10;14(9):5315-22
pubmed: 25164567
Ann Biomed Eng. 2012 Jun;40(6):1384-97
pubmed: 22065202
Int J Mol Sci. 2009 Sep 02;10(9):3811-23
pubmed: 19865520
Nano Lett. 2008 Feb;8(2):591-5
pubmed: 18162002
Biochem Pharmacol. 1987 Jul 15;36(14):2393-403
pubmed: 3038122
ACS Sens. 2019 May 24;4(5):1236-1244
pubmed: 31056899

Auteurs

Zvi Yaari (Z)

Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

Justin M Cheung (JM)

Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

Hanan A Baker (HA)

Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Department of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.

Rune S Frederiksen (RS)

Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

Prakrit V Jena (PV)

Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

Christopher P Horoszko (CP)

Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Department of Pharmacology, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.

Fang Jiao (F)

Department of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.
Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.

Simon Scheuring (S)

Department of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.
Department of Anesthesiology, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.

Minkui Luo (M)

Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Department of Pharmacology, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.

Daniel A Heller (DA)

Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Department of Physiology and Biophysics, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.
Department of Pharmacology, Weill Cornell Medicine, 1300 York Avenue, New York, New York 10065, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH